Financing ·
Jaguar Health, Inc. entered into two significant financing agreements on June 9, 2026
JAGXJaguar Health, Inc.
Jaguar Health, Inc. entered into two significant financing agreements on June 9, 2026. First, the company executed an Equity Line of Credit (ELOC) agreement with an institutional investor for up to $40 million in common stock purchases, featuring a $1.10 per share floor price. Second, the company completed a $2 million private placement of 240 shares of Series P Non-Convertible Preferred Stock. These Series P shares accrue dividends at an 8% annual rate, payable quarterly in either cash or common stock. The company obtained necessary stockholder approval for these transactions during its annual meeting on June 8, 2026. Jaguar Health, Inc. is a healthcare company focused on gastrointestinal health products.